BackForte Biosciences Overview

Forte Biosciences Current Cash

Track Forte Biosciences's current cash ($58M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$58.22M
↑ 26.97% YoYΔ $12.37M vs prior year quarter

Peer average

Loading

Forte Biosciences Current Cash History

Loading

Forte Biosciences vs. peers: Current Cash Comparison

Loading

Forte Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Forte Biosciences (FBRX) FAQ

Forte Biosciences (FBRX) currently reports a current cash of $58M as of March 2026. That compares with $46M in the prior-year period — up 27.0% year over year. Use the charts on this page to explore Forte Biosciences's current cash history and peer comparisons.

Forte Biosciences's current cash increased from $46M to $58M — a 27.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Forte Biosciences reported $58M in current cash as of March 2026. That compares with $46M in the prior-year period — up 27.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $58M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Forte Biosciences, and consider following FBRX for alerts when major investors trade the stock.

Forte Biosciences is classified in the Healthcare sector. On current cash, it currently shows $58M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FBRX with unrelated industries.